Therapy of acute myelogenous leukemia in adults.
Petti
M C
MC
Dept. of Hematology I, University, Rome, Italy.
Broccia
G
G
Caronia
F
F
Di Raimondo
F
F
Fioritoni
G
G
Ladogana
S
S
Leone
G
G
Liso
V
V
Musso
M
M
Neri
A
A
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007558:Italy / Q000453:epidemiology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D015993:Life Tables; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D015996:Survival Rate; D013866:Thioguanine / Q000008:administration & dosage
D003561:Cytarabine; D005047:Etoposide; D013866:Thioguanine; D003630:Daunorubicin